US 12,214,073 B2
Nutritional compositions for the management of hyponatremia
Lee Souders, Albuquerque, NM (US); and Bhupinder Singh, Phoenix, AZ (US)
Assigned to Nephcentric, LLC, Phoenix, AZ (US)
Filed by NEPHCENTRIC, LLC, Phoenix, AZ (US)
Filed on Apr. 4, 2022, as Appl. No. 17/713,134.
Application 17/713,134 is a continuation of application No. 17/063,327, filed on Oct. 5, 2020, granted, now 11,318,092.
Claims priority of provisional application 62/910,142, filed on Oct. 3, 2019.
Prior Publication US 2022/0226237 A1, Jul. 21, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 9/00 (2006.01); A61K 31/17 (2006.01); A61K 31/715 (2006.01); A61K 33/06 (2006.01); A61K 47/12 (2006.01); A61K 47/26 (2006.01)
CPC A61K 9/0095 (2013.01) [A61K 31/17 (2013.01); A61K 31/715 (2013.01); A61K 33/06 (2013.01); A61K 47/12 (2013.01); A61K 47/26 (2013.01); A61K 9/0053 (2013.01)] 7 Claims
 
1. A powder composition for treatment of hyponatremia comprising:
(a) 60-80 wt % urea;
(b) 7-12 wt % maltodextrin; and
(c) 5 wt % calcium silicate, wherein the powder composition is effective for treatment of hyponatremia.